Abstract
Bioresorbable vascular scaffold (BVS) is demonstrated to be clinical equivalent to drug eluting stents (DES) for the treatment of de-novo coronary artery disease. One of his properties is the thicker struts being completed degraded by 24-36 months. Data reporting clinical outcomes is scarce. We
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have